Budesonide suppresses pulmonary antibacterial host defense by down-regulating cathelicidin-related antimicrobial peptide in allergic inflammation mice and in lung epithelial cells
<p>Abstract</p> <p>Background</p> <p>Glucocorticoids are widely regarded as the most effective treatment for asthma. However, the direct impact of glucocorticoids on the innate immune system and antibacterial host defense during asthma remain unclear. Understanding the...
Main Authors: | Wang Peng, Wang Xiaoyun, Yang Xiaoqiong, Liu Zhigang, Wu Min, Li Guoping |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-02-01
|
Series: | BMC Immunology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2172/14/7 |
Similar Items
-
The specific use of budesonide in the treatment of allergic rhinitis
by: S. V. Tsarev
Published: (2016-12-01) -
Effect of pre-seasonal seasonal treatment with budesonide topical nasal powder in patients with seasonal allergic rhinitis
by: Maria C Morelli, et al.
Published: (1996-01-01) -
Effect of budesonide and cetirizine hydrochloride on neurotrophic factor, airway function and chemokines CCL17 and CCL22 in patients with allergic rhinitis
by: Xiang Xu, et al.
Published: (2017-11-01) -
Cathelicidins: Immunomodulatory Antimicrobials
by: Roel M. van Harten, et al.
Published: (2018-09-01) -
Tissue expression and developmental regulation of chicken cathelicidin antimicrobial peptides
by: Achanta Mallika, et al.
Published: (2012-05-01)